胰管和胆管支架的全球市场 - 市场规模（按细分市场）、份额、监管、报销、治疗、预测（截至 2033 年）

胰管和胆管支架市场主要由导致胆管和胰管阻塞的疾病所驱动。 ERCP 和 PTC 手术数量的增加正在推动市场，特别是需要支架置入和重复支架置入的手术。

本报告研究和分析了全球胰管支架/胆道支架市场，并提供了有关每个细分市场的市场规模、市场趋势、竞争格局以及 COVID-19 影响的资讯。

市场模型的主要内容如下。

商用胰管支架与胆道支架的竞争格局不断变化

• 对主要产业趋势的考虑
• 按胰管支架/胆管支架市场细分的年收入和市场前景（2015-2033）
• 按细分市场划分的手术总数、单位数量、平均售价和市场价值的详细数据

全球、区域和国家层面的特定市场考量

• 按地区细分全球趋势的特定市场定性资讯和国家/地区考虑因素
• 胰管支架/胆管支架市场SWOT分析
• 胰管支架/胆管支架市场竞争动态思考及趋势

透过对医疗保健系统的真实、全面的了解来促进市场了解。 市场进入部分还提供有关报销政策和监管环境的信息，使您能够更深入地研究市场动态。

• 各国医疗保健系统概览
• 按国家/地区划分的报销政策
• 各国医疗科技监理状况

目标公司

• Boston Scientific Corp
• Becton Dickinson and Co
• Hellman & Friedman LLC
• ConMed Corp
• Cook Group Inc
• Hobbs Medical Inc
• Medtronic Plc
• Olympus Corp
• W. L. Gore & Associates Inc
• 其他

Abstract

Pancreatic and Biliary stent Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within General Surgery Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Pancreatic and Biliary Stents market for the year 2020 and beyond. Pancreatic and Biliary Stents are the tubular devices made either of plastic or metal. They are often used in the treatment of obstructive jaundice from either benign or malignant causes and in the management of biliary leaks. These stents are also for preventing post- endoscopic retrograde cholangiopancreatography pancreatitis and to drain the gallbladder and pancreatic fluids. These stents are placed through two major procedures: Endoscopic Retrograde Cholangio-Pancreatography (ERCP) and Percutaneous transhepatic cholangiography (PTC).

The Pancreatic and Biliary Stents market is mainly driven by the diseases resulting in the obstruction in bile or pancreatic ducts. Increase in the number of ERCP and PTC procedures has fuelled the market especially the procedures requiring stenting and recurrent stenting.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are:

Currently marketed Pancreatic and Biliary Stents and evolving competitive landscape:

• Insightful review of the key industry trends.
• Annualized total Pancreatic and Biliary Stents market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights:

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Pancreatic and Biliary stent market.
• Competitive dynamics insights and trends provided for Pancreatic and Biliary stent market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Boston Scientific Corp, Becton Dickinson and Co, Hellman & Friedman LLC, ConMed Corp, Cook Group Inc, Hobbs Medical Inc, Medtronic Plc, Olympus Corp, W. L. Gore & Associates Inc, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

CMO executives who must have deep understanding of the Pancreatic and Biliary Stents marketplace to make strategic planning and investment decisions.

Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.

Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

Understand the impact of COVID-19 on Pancreatic and Biliary Stents market.

Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.

Develop business strategies by understanding the trends shaping and driving Pancreatic and Biliary Stents market.

Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Pancreatic and Biliary Stents market in the future.

Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.

Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

Track device sales in the global and country-specific Pancreatic and Biliary Stents market from 2015-2033.

Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents

Not Applicable

List of Tables

Not Applicable

List of Figures

Not Applicable